about
Adenovirus-mediated interleukin-12 gene transfer combined with cytosine deaminase followed by 5-fluorocytosine treatment exerts potent antitumor activity in Renca tumor-bearing mice.Characterization of chemically induced ovarian carcinomas in an ethanol-preferring rat model: influence of long-term melatonin treatmentSynthetic control of mammalian-cell motility by engineering chemotaxis to an orthogonal bioinert chemical signal.Dynamic distribution and expression in vivo of the human interferon gamma gene delivered by adenoviral vector.Electroporation for the delivery of DNA-based vaccines and immunotherapeutics: current clinical developmentsMelatonin attenuates the TLR4-mediated inflammatory response through MyD88- and TRIF-dependent signaling pathways in an in vivo model of ovarian cancerOptimizing DC vaccination by combination with oncolytic adenovirus coexpressing IL-12 and GM-CSF.Conditional interleukin-12 gene therapy promotes safe and effective antitumor immunity.Characterisation of systemic dissemination of nonreplicating adenoviral vectors from tumours in local gene deliveryAdenoviral endoplasmic reticulum-targeted mda-7/interleukin-24 vector enhances human cancer cell killing.MDA-7 results in downregulation of AKT concomitant with apoptosis and cell cycle arrest in breast cancer cells.Gene therapy based on interleukin-12 loaded chitosan nanoparticles in a mouse model of fibrosarcoma.Immunotherapy of tumors with recombinant adenovirus encoding macrophage inflammatory protein 3beta induces tumor-specific immune response in immunocompetent tumor-bearing miceRasayans and non-rasayans herbs: Future immunodrug - TargetsAntitumor immune activity by chemokine CX3CL1 in an orthotopic implantation of lung cancer model in vivo.Analysis of the expression of SDF-1 splicing variants in human colorectal cancer and normal mucosa tissues.Tumor Necrosis Factor (TNF) and Chemokines in Colitis-Associated Cancer.Soluble PD-L1 as a Biomarker in Malignant Melanoma Treated with Checkpoint Blockade.
P2860
Q24815069-16D5DC82-BC34-45CF-BE54-EFDC52708084Q28537709-90CF05C5-9FE4-423F-89E7-6A80665D37B4Q30577136-3CC63B2E-4221-46F0-A76B-E87D3A9CD48AQ33409158-2D85789B-FDE1-48A2-9124-62E0198CBC0EQ33713435-5E9BFFA8-EE39-4C21-848F-7DE7D2EBC945Q35066004-C026A9D7-8F0B-4D2E-84DE-7410B0D0AAC6Q35144428-0DDB2A96-1028-4BB4-9594-F4B19B937074Q36190053-8D8BFE8E-A2D1-444C-9067-3861C8F8651EQ36616672-52CC2AB4-400F-49A9-A408-30B482B47545Q37001673-E0F96437-C665-4105-898A-747EB017D612Q37419724-DA49879B-8826-45A8-87B7-2490A42B9864Q37447729-01D17277-0B67-424C-A099-F22B10F0E24CQ37728133-3B4D7D3C-CC23-4369-957F-DBD9604748F5Q38172095-E8D66B8F-DB89-4FCC-81B0-74B102934F21Q38292325-21A9A361-DC6A-420D-9630-CD7A26D196BEQ38720716-790F93B4-817C-4DD7-9D54-E8E0A1912F86Q42109061-39EF6D68-6F9A-414B-AE29-23549BE3B894Q50993649-780A5F01-A298-401F-B537-94B800E0E9B1
P2860
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Cytokine- and chemokine-based gene therapy for cancer.
@ast
Cytokine- and chemokine-based gene therapy for cancer.
@en
type
label
Cytokine- and chemokine-based gene therapy for cancer.
@ast
Cytokine- and chemokine-based gene therapy for cancer.
@en
prefLabel
Cytokine- and chemokine-based gene therapy for cancer.
@ast
Cytokine- and chemokine-based gene therapy for cancer.
@en
P2093
P1476
Cytokine- and chemokine-based gene therapy for cancer
@en
P2093
Abner M Mhashilkar
Rajagopal Ramesh
Sunil Chada
P304
P577
2003-10-01T00:00:00Z